Eye gaze artwork of #NurOwn P3 trial participant who is dying of #ALS .

Now unblinded, this #Oklahoman KNOWS he received NurOwn in the trial. He has been saying for years that NurOwn helped him regain function in 2019-2020.

How inhumane that our regulatory system ignored the…

NurOwn is an effective treatment for ALS. it’s time to let the science speak with the 3b trial results.
#NUTOWNWORKS

.Dr. Robert M. Califf
FDA Biologics
Thousands of people with #ALS will die horrible deaths while #Nurown 3b results come in.
There has to be the way to approve #NurOwn now. #Relyvrio

Average person with #ALS loses 1 pt/mo in function on the ALSFRS-R scale. Before the 1st #NurOwn injection, this trial participant was a “fast progressor,” losing 1.43 pts/mo.

After receiving NurOwn, this person almost immediately HALTED THEIR PROGRESSION -- consistent with the…

More proof that #NurOwn works in #ALS !
Biomarker paper published in Muscle & Nerve

🔹CSF samples taken 7x during 28 wk trial to analyze impact of 3 doses on 45 pre-specified #biomarkers

🔹3 biomarkers were predictive of clinical outcomes:
1️⃣ Galcetin-1 ...…

GREAT NEWS! The FDA has approved the Phase 3b trial design for #NurOwn aka debamestrocel!

TRIAL DESIGN
🔹≈200 trial participants
🔹1:1 placebo ratio
🔹24 wk double-blinded trial
🔹24 wk OLE where all participants can get NurOwn
🔹6-9 wk screening to do Bone Marrow Aspiration…

Jamie is long gone if you are wondering Dr. Robert M. Califf FDA Biologics. She fought hard for a chance at #NurOwn . Her daughter lost her mom, her mom lost her child, her sister lost her bestie. All because of your ignorance.

I believe NurOwn is an effective treatment for ALS. & for those who opposed NurOwn last go around, it’s time to let the science speak with the 3b trial results. We’ve had many loses recently including Amx0036, a negative trial for edaravone, negative Tudca and trehalose. +

Fast forward Two Years. FDA Biologics this is your design. Your doing. A result of your decision making. Thousands more dead who haven’t had a chance to benefit like Sandy or the many others who saw benefit from #NurOwn . Since her post we have witnessed FDA Biologics prioritize and…

Just so we're clear: Let's say, lower NfL is indeed a good thing for some drugs for #ALS , it's also good for #NurOwn right? BioSpace STAT #endals FiercePharma U.S. FDA #NurOwn works ir.brainstorm-cell.com/2024-04-10-Bra…

Brainstorm is about to start another Trial for NUROWN. How many VICTIMS will DIE waiting?
U.S. FDA
FDA Biologics
FDA Commissioner
Dr. Robert M. Califf

Excited to see the new Biomarkers data from the #NurOwn Expanded Access Program at the 3rd Annual #ALS Drug Development Summit May 21-23

Deb Bellina ALS/MNDMamaBears
Kandy Simons Mitze Klingenberg BSN, RN
BridgetRebecca ᴊᴀɴɪᴇ Jan Mattingly gina Gibson Liz text LOVE to 644-33 🇺🇦🌻 Shelly D.…

David, what is baffling is how obsessed you are with your intent on trying to destroy NurOwn. Many people benefited in the past. They are doing another trial. Thank you BrainStorm for not giving up. I can’t wait to watch as NurOwn furthers science. That IS what it is all…

Kevin Ness Vivek Ramaswamy lindsey vonn Phil Rosenthal This company needs help. Please invest in the trial. Get Nurown into bodies

The U.S. FDA has given BrainStorm a positive Special Protocol Assessment (SPA) for its phase 3b trial of NurOwn. #cureALStogether

The FDA has agreed that the design of a Phase 3b trial is generally adequate to back a potential regulatory application for NurOwn for ALS. alsnewstoday.com/news/fda-oks-p…

'Frankly eye-popping!'
That's what renowned ALS researcher, Dr. Bob Brown of UMass Chan Medical School, said about #NurOwn biomarker results when speaking with other researchers at the ALS/MND Conference on December 10, 2021.

Now we know why.
Dr. Brown is the senior author on the NurOwn…

Ken M gina Gibson C Lebovits It would be more fair to negotiate with FDA to let current patients to have Nurown and go ahead with 3b phase.
So many efforts by so many people were put in Nurown but we can't wait for another trial.

Colorado22yr. ALS Research shows the minute Brainstorm and NurOwn stem cells collaborate with this project these cells properly adhere and become effective in everyone. Regardless of progression. Adjust the body to receive these cells from biophysics trigger and cause. Simplify.

Colorado22yr. ALS Research shows the minute Brainstorm and NurOwn stem cells collaborate with this project these cells properly adhere and become effective in everyone. Regardless of progression. Adjust the body to receive these cells from actual trigger and cause. Simplification